SPC486
Aprocitentan eða lyfjafræðilega viðunandi salt þar af
Status:
VeittApplication date:
4.12.2024Application published:
15.1.2025Grant published:
15.12.2025
Max expiry date:
14.8.2033Medicine name:
JeraygoMedicine for children:
No
Timeline
Today
4.12.2024Application
15.1.2025Publication
15.12.2025Registration
14.8.2033Expires
Marketing license
IS authorization number:
EU/1/24/1818Date:
16.8.2024
Foreign authorization number:
EU/1/24/1818Date:
27.6.2024
Owner
Name:
Idorsia Pharmaceuticals LtdAddress:
Hegenheimermattweg 91, Allschwil CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2190837
Deadlines
TypeDeadline until
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 22.11.2025